Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Curis (CRIS) EBITDA (2016 - 2025)

Curis (CRIS) has disclosed EBITDA for 16 consecutive years, with -$7.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA rose 23.73% year-over-year to -$7.7 million, compared with a TTM value of -$36.6 million through Sep 2025, up 19.81%, and an annual FY2024 reading of -$43.6 million, up 7.19% over the prior year.
  • EBITDA was -$7.7 million for Q3 2025 at Curis, up from -$8.6 million in the prior quarter.
  • Across five years, EBITDA topped out at -$7.7 million in Q3 2025 and bottomed at -$16.5 million in Q1 2022.
  • Average EBITDA over 5 years is -$11.6 million, with a median of -$11.4 million recorded in 2023.
  • The sharpest move saw EBITDA crashed 84.98% in 2021, then surged 30.92% in 2023.
  • Year by year, EBITDA stood at -$13.7 million in 2021, then grew by 19.6% to -$11.0 million in 2022, then decreased by 4.98% to -$11.6 million in 2023, then grew by 16.99% to -$9.6 million in 2024, then grew by 19.64% to -$7.7 million in 2025.
  • Business Quant data shows EBITDA for CRIS at -$7.7 million in Q3 2025, -$8.6 million in Q2 2025, and -$10.6 million in Q1 2025.